Dianne Nicol

Dianne Nicol

University of Tasmania

H-index: 32

Oceania-Australia

About Dianne Nicol

Dianne Nicol, With an exceptional h-index of 32 and a recent h-index of 23 (since 2020), a distinguished researcher at University of Tasmania, specializes in the field of intellectual property, biotechnology.

His recent articles reflect a diverse array of research interests and contributions to the field:

A systematic literature review of the ‘commercialisation effect’on public attitudes towards biobank and genomic data repositories

Australian researchers' perceptions and experiences with stem cell registration.

How do we protect biomedical research in the evolving intellectual property environment?

The Australian Citizens’ Jury and Global Citizens’ Assembly on Genome Editing

Points to consider in the development of national human genome editing policy

Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support

Bioethical Decision-Making About Somatic Cell Genome Editing: Sickle-Cell Disease as a Case Study

The Patent Landscape for CRISPR Genome Editing in Australia.

Dianne Nicol Information

University

Position

Professor of Law

Citations(all)

3276

Citations(since 2020)

1454

Cited By

2288

hIndex(all)

32

hIndex(since 2020)

23

i10Index(all)

62

i10Index(since 2020)

39

Email

University Profile Page

University of Tasmania

Google Scholar

View Google Scholar Profile

Dianne Nicol Skills & Research Interests

intellectual property

biotechnology

Top articles of Dianne Nicol

Title

Journal

Author(s)

Publication Date

A systematic literature review of the ‘commercialisation effect’on public attitudes towards biobank and genomic data repositories

Jarrod Walshe

Brad Elphinstone

Dianne Nicol

Mark Taylor

2024/2/22

Australian researchers' perceptions and experiences with stem cell registration.

bioRxiv

Mengqi Hu

Dan Santos

Edilene Lopes

Dianne Nicol

Andreas Kurtz

...

2024

How do we protect biomedical research in the evolving intellectual property environment?

Dianne Nicol

Jane Nielsen

2023/3/17

The Australian Citizens’ Jury and Global Citizens’ Assembly on Genome Editing

The American Journal of Bioethics

Dianne Nicol

John Stanley Dryzek

Simon Niemeyer

Nicole Curato

Rebecca Paxton

2023/7/3

Points to consider in the development of national human genome editing policy

Dianne Nicol

Simon Niemeyer

Rebecca Paxton

Christopher Rudge

2023

Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support

Medical Journal of Australia

Deborah Gleeson

James Scheibner

Dianne Nicol

2023/7

Bioethical Decision-Making About Somatic Cell Genome Editing: Sickle-Cell Disease as a Case Study

Christopher Rudge

Dianne Nicol

2023/6/15

The Patent Landscape for CRISPR Genome Editing in Australia.

Journal of Law & Medicine

Naomi Foo

Olumayowa Adesanya

Jane Nielsen

Dianne Nicol

2023/6/1

The GA4GH Regulatory and Ethics Work Stream (REWS) at 10: An Interdisciplinary, Participative Approach to International Policy Development in Genomics

Yann Joly

Edward Dove

Bartha Maria Knoppers

Dianne Nicol

2023/12/20

Context matters in genomic data sharing: a qualitative investigation into responses from the Australian public

BMC Medical Genomics

Vanessa Warren

Christine Critchley

Rebekah McWhirter

Jarrod Walshe

Dianne Nicol

2023/4/1

The Australian'Valley of Death'? Australian research and patenting practices in bioprinting and genome editing

Jane Nielsen

Dianne Nicol

Cameron Stewart

2023/7/14

How Should We Regulate Heritable Human Genome Editing in Australia?

Journal of Law & Medicine

Dianne Nicol

Christopher Rudge

Rebecca Paxton

Simon Niemeyer

2022/6/1

NEGLIGENCE AND HEALTH INNOVATION: ISSUES WITH THE STANDARD OF CARE AND THE NEED TO REVISIT THE VOLUNTARY ASSUMPTION OF RISK.

Journal of Law & Medicine

Cameron Stewart

Lisa Eckstein

Dianne Nicol

Jane Nielsen

2022/6/1

Return of genomic results does not motivate intent to participate in research for all: Perspectives across 22 countries

Genetics in Medicine

Richard Milne

Katherine I Morley

Mohamed A Almarri

Jerome Atutornu

Elena E Baranova

...

2022/5/1

Intellectual property waiver for COVID vaccines should be expanded to include treatments and tests

Deborah Gleeson

Dianne Nicol

James Scheibner

2022/11/22

Genome editing: Formulating an Australian community response: Report to decision makers, stakeholders, and members of the public

Dianne Nicol

Rebecca Paxton

Simon Niemeyer

Nicole Curato

John Dryzek

...

2022

An ethico-legal assessment of intellectual property rights and their effect on COVID-19 vaccine distribution: an Australian case study

Journal of Law and the Biosciences

James Scheibner

Jane Nielsen

Dianne Nicol

2022/7/12

Non-invasive prenatal testing and the resilience of the patent system

Dianne Nicol

Jane Nielsen

2022/7/8

Essentially Ours: Assessing the regulation of the collection and use of health-related genomic information

Rebekah McWhirter

Lisa Eckstein

Donald Chalmers

Jane Kaye

Jane Nielsen

...

2021/1/1

Integrating public participation, transparency and accountability into governance of marketing authorisation for genome editing products

Jane Nielsen

Lisa Eckstein

Dianne Nicol

Cameron Stewart

2021/10/15

See List of Professors in Dianne Nicol University(University of Tasmania)

Co-Authors

H-index: 73
Ian Meinertzhagen

Ian Meinertzhagen

Dalhousie University

H-index: 50
Stephanie Malia Fullerton

Stephanie Malia Fullerton

University of Washington

H-index: 45
Robert Cook-Deegan

Robert Cook-Deegan

Arizona State University

H-index: 36
Jo Dickinson

Jo Dickinson

University of Tasmania

H-index: 34
Jantina de Vries

Jantina de Vries

University of Cape Town

H-index: 32
Christine Critchley

Christine Critchley

Swinburne University of Technology

academic-engine